Cara Therapeutics (CARA) director Shiff received 150,647 shares

Insider transactions reported

Susan Ph.D. Shiff (director at Cara Therapeutics Inc., CARA) reported that they received 150,647 shares on Jun 4, 2024. After these transactions the filing shows 202,085 shares held directly.

Reporting person

Shiff Susan Ph.D.

Options and other derivatives

Holdings before and after

• Common Stock: 51,438 to 202,085 direct
• Stock Option (Right to Buy): 0 to 195,000 direct

Footnotes from the filing

1. 1. Represents the number of shares underlying restricted stock units ( RSUs ) granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of (i) June 4, 2025 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.
2. 2. This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 4, 2025 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ